An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer

Endocrinology and Metabolism Clinics of North America - Tập 37 Số 2 - Trang 457-480 - 2008
Anna M. Sawka1,2, James D. Brierley3,4, Richard Tsang3,4, Lehana Thabane5,6, Lorne Rotstein7,8, Amiram Gafni9,6, Sharon E. Straus10,11, David P. Goldstein12
1Division of Endocrinology and Department of Medicine, University Health Network, Toronto, ON, Canada
2Division of Endocrinology and Department of Medicine, University of Toronto, Toronto, ON, Canada
3Department of Radiation Oncology, University Health Network Toronto, ON, Canada
4Department of Radiation Oncology, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada
5Centre for Evaluation of Medicines, St. Joseph's Healthcare, 105 Main Street East, Level P1, Hamilton, ON L8N 1G6, Canada
6Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada
7Department of Surgery, University Health Network, Toronto, ON, Canada
8Department of Surgery, University of Toronto, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
9Centre for Health Economics and Policy Analysis, McMaster University, 1200 Main Street West, 3H29, Hamilton, ON L8N 3Z5, Canada
10Department of Knowledge Translation, University of Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada
11Division of Geriatrics and Department of Medicine, University of Calgary, Calgary, AB, Canada
12Department of Otolaryngology Head and Neck Surgery, University of Toronto, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, Public Health Agency of Canada. Canadian cancer statistics 2005. Available at: http://www.cancer.ca. Accessed August 2, 2005.

Hayat, 2007, Cancer statistics, trends, and multiple primary cancers from the Surveillance, Epidemiology, and End Results (SEER) Program, Oncologist, 12, 20, 10.1634/theoncologist.12-1-20

Davies, 2006, Epidemiology of head and neck cancer in the United States, Otolaryngol Head Neck Surg, 135, 451, 10.1016/j.otohns.2006.01.029

Jonklaas, 2006, Outcomes of patients with differentiated thyroid carcinoma following initial therapy, Thyroid, 16, 1229, 10.1089/thy.2006.16.1229

Eustatia-Rutten, 2006, Survival and death causes in differentiated thyroid carcinoma, J Clin Endocrinol Metab, 91, 313, 10.1210/jc.2005-1322

Cooper, 2006, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 16, 109, 10.1089/thy.2006.16.109

National Cancer Institute. Thyroid cancer (PDQ): treatment. 2006. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/thyroid/healthprofessional/allpages Accessed July 23, 2006.

Pacini, 2006, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158

American Association of Clinical Endocrinologists, American College of Endocrinology, American Association of Endocrine Surgeons, 2001, AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma, Endocr Pract, 7, 202, 10.4158/EP.7.3.202

British Thyroid Association, Royal College of Physicians. 2007 Guidelines for the management of thyroid cancer. 2nd edition. Available at: http://www.british-thyroid-association.org. Accessed October 20, 2007.

Sawka, 2004, Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer, J Clin Endocrinol Metab, 89, 3668, 10.1210/jc.2003-031167

Vini, 2003, Long-term results in elderly patients with differentiated thyroid carcinoma, Cancer, 97, 2736, 10.1002/cncr.11410

Brierley, 2005, Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single Canadian institution over 40 years, Clin Endocrinol (Oxf), 63, 418, 10.1111/j.1365-2265.2005.02358.x

Lang, 2007, Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging, Ann Surg Oncol, 14, 730, 10.1245/s10434-006-9207-5

Pelizzo, 2007, Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients, Clin Nucl Med, 32, 440, 10.1097/RLU.0b013e31805375ca

Lundgren, 2007, Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer, Br J Surg, 94, 571, 10.1002/bjs.5635

Yildrim, 2005, A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems, J Am Coll Surg, 200, 378, 10.1016/j.jamcollsurg.2004.10.031

Pelizzo, 2004, Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience, Nucl Med Commun, 25, 547, 10.1097/01.mnm.0000126625.17166.36

Mazzaferri, 2001, Clinical Review 128: current approaches to primary therapy for papillary and follicular thyroid cancer, J Clin Endocrinol Metab, 86, 1447, 10.1210/jc.86.4.1447

Chow, 2002, Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy, Int J Radiat Oncol Biol Phys, 52, 784, 10.1016/S0360-3016(01)02686-4

Chow, 2002, Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute, Head Neck, 24, 670, 10.1002/hed.10080

Balan, 1994, 1994 Outcome of 249 patients attending a nuclear medicine department with well differentiated thyroid cancer; a 23 year review, Br J Radiol, 67, 283, 10.1259/0007-1285-67-795-283

Cunningham, 1990, Survival discriminants for differentiated thyroid cancer, Am J Surg, 160, 344, 10.1016/S0002-9610(05)80539-2

Loh, 1997, Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients, J Clin Endocrinol Metab, 82, 3553, 10.1210/jc.82.11.3553

Martins, 1997, Management of thyroid cancer of follicular cell origin: Gundersen/Lutheran Medical Center, 1969–1995, J Am Coll Surg, 185, 388

Baudin, 1998, Microcarcinoma of the thyroid gland the Gustave-Roussy Institute experience, Cancer, 83, 553, 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U

Samaan, 1992, The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients, J Clin Endocrinol Metab, 75, 714, 10.1210/jc.75.3.714

Herrera, 1996, Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors, World J Surg, 20, 94, 10.1007/s002689900017

Simpson, 1988, Papillary and follicular thyroid cancer: impact of treatment in 1578 patients, Int J Radiat Oncol Biol Phys, 14, 1063, 10.1016/0360-3016(88)90381-1

Carcangiu, 1985, Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy, Cancer, 55, 805, 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO;2-Z

Hay, 2002, Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000, Trans Am Clin Climatol Assoc, 113, 241

DeGroot, 1990, Natural history, treatment, and course of papillary thyroid carcinoma, J Clin Endocrinol Metab, 71, 414, 10.1210/jcem-71-2-414

Gemsenjager, 2001, Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years, Swiss Med Wkly, 131, 157

McHenry, 1991, Prospective management of nodal metastases in differentiated thyroid cancer, Am J Surg, 162, 353, 10.1016/0002-9610(91)90147-6

Morris, 1998, Localized well-differentiated thyroid carcinoma: survival analysis of prognostic factors and (131)I therapy, Ann Surg Oncol, 5, 329, 10.1007/BF02303496

Tseng, 1996, The surgical treatment and prognostic factors of well-differentiated thyroid cancers in Chinese patients: a 20-year experience, Zhonghua Yi Xue Za Zhi (Taipei), 58, 121

Davis, 1992, Efficacy of 131I ablation following thyroidectomy in patients with invasive follicular thyroid cancer, Am J Surg, 163, 472, 10.1016/0002-9610(92)90390-D

Saadi, 2001, Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma, Surgery, 130, 30, 10.1067/msy.2001.115364

Sanders, 1998, Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy, Surgery, 124, 967, 10.1016/S0039-6060(98)70036-4

Tsang, 1998, The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma, Cancer, 82, 375, 10.1002/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-V

Chow, 2003, Changes in presentation, management, and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000, Clin Oncol (R Coll Radiol), 15, 329, 10.1016/S0936-6555(03)00066-9

Chow, 2006, Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition, Endocr Relat Cancer, 13, 1159, 10.1677/erc.1.01320

Chow, 2003, Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality, Cancer, 98, 31, 10.1002/cncr.11442

Hay, 2006, Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma, J Surg Oncol, 94, 692, 10.1002/jso.20696

Hackshaw, 2007, I-131 activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review, J Clin Endocrinol Metab, 92, 28, 10.1210/jc.2006-1345

Pilli, 2007, A comparison of 1859 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer, J Clin Endocrinol Metab, 92, 3542, 10.1210/jc.2007-0225

Swaka, 2008, Basis for physician recommendations for adjuvant radioactive iodine in early stage thyroid carcinoma: principal findings of the CAM-ThyrCa Survey, Endocr Prac, 14, 175, 10.4158/EP.14.2.175

Thông tin
Thông tin xuất bản

Endocrinology and Metabolism Clinics of North America

Tập 37 Số 2

457-480

Thông tin tác giả